Contract 68HE0B22P0349
Bio-Rad Laboratories, Inc. · Environmental Protection Agency · April 5, 2022
Bio-Rad Laboratories, Inc. was awarded a federal contract by Environmental Protection Agency on April 5, 2022 for $15,000 of work in biological product (except diagnostic) manufacturing. Performance is in Hercules, CA. It was awarded under full and open competition. The contract has been modified 1 time since the base award It uses firm fixed-price contract pricing. The most recent modification was on September 26, 2022.
Contract details
- PIID
- 68HE0B22P0349
- Award type
- Purchase Order
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Competed Under Sap
- NAICS
- 325414 · Biological Product (Except Diagnostic) Manufacturing
- Product / service
- Laboratory Equipment And Supplies
- Place of performance
- Hercules, CA
- First action
- April 5, 2022
- Latest action
- September 26, 2022
Description
P00001 - FUNDING MOD - REAGENTS FOR BIORAD QX200/QX100 DDPCR SYSTEM
Modification timeline
-
September 26, 2022Mod P00001$-50
-
April 5, 2022Base awardREAGENTS FOR BIORAD QX200/QX100 DDPCR SYSTEM$15.2K
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Bio-Rad Laboratories, Inc. | Environmental Protection Agency | September 30, 2022 | $25.0K |
| Lexogen Inc | Environmental Protection Agency | September 27, 2022 | $67.3K |
| Life Technologies Corporation | Environmental Protection Agency | August 29, 2011 | $18 |
| Kirkegaard & Perry Laboratories, Inc. | Environmental Protection Agency | July 11, 2011 | $0 |
| Asuragen Incorporated | Environmental Protection Agency | January 5, 2011 | $12.0K |
| University Of Florida | Environmental Protection Agency | November 17, 2010 | $0 |
Top contractors in NAICS 325414
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Pfizer Inc | 3 | $15.27B |
| 2 | Sanofi Vaccines Us Inc. | 606 | $9.38B |
| 3 | Regeneron Pharmaceuticals Inc | 1 | $5.57B |
| 4 | Merck Sharp & Dohme Corp. | 56 | $3.99B |
| 5 | Emergent Biodefense Operations Lansing Llc | 16 | $3.34B |
| 6 | Merck Sharp & Dohme Llc | 15 | $3.33B |
| 7 | Pfizer Inc. | 25 | $3.11B |
| 8 | Glaxosmithkline Holdings (Americas) Inc. | 109 | $2.24B |
| 9 | Modernatx, Inc. | 1 | $1.75B |
| 10 | Bavarian Nordic A/S | 1 | $1.01B |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 68HE0B22P0349?
Contract 68HE0B22P0349 is a federal contract awarded to Bio-Rad Laboratories, Inc. by Environmental Protection Agency on April 5, 2022 for $15,000 of work classified under BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING. It has been modified 1 time since the base award.
Who won contract 68HE0B22P0349?
Bio-Rad Laboratories, Inc. won contract 68HE0B22P0349 from Environmental Protection Agency.
How much is contract 68HE0B22P0349 worth?
Contract 68HE0B22P0349 has obligated $15,000 to date.